Dare Bioscience (DARE) Net Cash Flow (2013 - 2025)
Dare Bioscience's (DARE) quarterly Net Cash Flow came in at $1.7 million in Q4 2025, down 63.33% YoY from $4.5 million in Q4 2024, and down 90.79% on a QoQ basis from $18.0 million in Q3 2025.
Dare Bioscience (DARE) Net Cash Flow (2013 - 2025) Analysis & Trends
Dare Bioscience (DARE) has 13 years of Net Cash Flow data on file, last reported at $1.7 million in Q4 2025.
- Quarterly Net Cash Flow fell 63.33% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.0 million (up 71.38% YoY) and the FY2025 annual result came in at $9.0 million, up 71.38% from the prior year.
- Net Cash Flow slipped to $1.7 million in Q4 2025, from $18.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $36.5 million in Q3 2021 to a low of -$14.8 million in Q1 2023.
- A 5-year average of $1.0 million and a median of -$1.4 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2021 — Net Cash Flow jumped 87127.9% — and 2024, when it sank 996.92%.
- Tracing DARE's Net Cash Flow over 5 years: stood at $6.1 million in 2021, then slumped by 196.9% to -$5.9 million in 2022, then jumped by 41.06% to -$3.5 million in 2023, then soared by 230.34% to $4.5 million in 2024, then tumbled by 63.33% to $1.7 million in 2025.
- The last three Net Cash Flow figures came in at $1.7 million (Q4 2025), $18.0 million (Q3 2025), and -$5.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 225.59 Mn |
| 10 | Dare Bioscience | 12.42 Mn | -196,495.78 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 18.03 Mn |
| Sep 30, 2025 | 18.03 Mn |
| Jun 30, 2025 | -5.28 Mn |
| Jun 30, 2025 | -5.28 Mn |
| Mar 31, 2025 | -5.41 Mn |
| Mar 31, 2025 | -5.41 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Jun 30, 2024 | 12.73 Mn |
| Jun 30, 2024 | 12.73 Mn |
| Mar 31, 2024 | -6.81 Mn |
| Mar 31, 2024 | -6.81 Mn |
| Dec 31, 2023 | -3.48 Mn |
| Dec 31, 2023 | -3.48 Mn |
| Sep 30, 2023 | 580,352.00 |
| Sep 30, 2023 | 580,352.00 |